Business Description
NP Life Sciences Health Industry Group Inc
NAICS : 611610
SIC : 8732
ISIN : US36253J2050
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.23 | |||||
Equity-to-Asset | -6 | |||||
Debt-to-Equity | -0.73 | |||||
Debt-to-EBITDA | -0.19 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -151.7 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year FCF Growth Rate | 12.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 0.13 | |||||
14-Day RSI | 0.86 | |||||
6-1 Month Momentum % | -82.03 | |||||
12-1 Month Momentum % | -89.43 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.14 | |||||
Quick Ratio | 0.14 | |||||
Cash Ratio | 0.14 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -425 | |||||
Net Margin % | -353.57 | |||||
FCF Margin % | -432.14 | |||||
ROE % | -611.11 | |||||
ROA % | -140.63 | |||||
ROIC % | -633.39 | |||||
ROCE % | -577.67 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 13.48 | |||||
EV-to-EBIT | -19.61 | |||||
EV-to-EBITDA | -19.61 | |||||
EV-to-Revenue | 83.32 | |||||
EV-to-FCF | -19.28 | |||||
Earnings Yield (Greenblatt) % | -5.1 | |||||
FCF Yield % | -5.22 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:NPLS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
NP Life Sciences Health Industry Group Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.028 | ||
EPS (TTM) ($) | -0.002 | ||
Beta | 0.49 | ||
Volatility % | 89.63 | ||
14-Day RSI | 0.86 | ||
14-Day ATR ($) | 0.000046 | ||
20-Day SMA ($) | 0.0539 | ||
12-1 Month Momentum % | -89.43 | ||
52-Week Range ($) | 0.0539 - 0.65 | ||
Shares Outstanding (Mil) | 42.96 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
NP Life Sciences Health Industry Group Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
NP Life Sciences Health Industry Group Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
NP Life Sciences Health Industry Group Inc Frequently Asked Questions
What is NP Life Sciences Health Industry Group Inc(NPLS)'s stock price today?
When is next earnings date of NP Life Sciences Health Industry Group Inc(NPLS)?
Does NP Life Sciences Health Industry Group Inc(NPLS) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |